Starton Therapeutics Inc. — Form D

Starton Therapeutics Inc. of PARAMUS, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2022-02-16. The offering totals $1.1M, of which $1.1M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (23)

NameRoleLocation
Cidnee VaykovichDirectorNew York, NY
Pedro WaismanDirectorParamus, NJ
Keith DarraghExecutive OfficerParamus, NJ
Pedro WaismanExecutive OfficerParamus, NJ
Nitin KaushalDirectorKelowna, A1
Scott KahnExecutive OfficerParamus, NJ
Mohamad HusseinDirectorMelbourne Beach, FL
Eric BaumDirectorCharlotte, NC
Roy WaldronDirectorFort Lauderdale, FL
Asher Chanan-KhanDirectorJacksonville, FL
Pedro Lichtinger WaismanDirectorSunny Isles Beach, FL
Pedro Lichtinger WaismanExecutive OfficerSunny Isles Beach, FL
Kenneth AndersonDirectorWellesley, MA
Moses DodoDirectorCoral Gables, FL
Fotios PlakogiannisDirectorWhitestone, NY
Jamie OliverExecutive OfficerRaleigh, NC
Cidnee VaykovichExecutive OfficerNew York, NY
PEDRO LICHTINGERDirectorPARAMUS, NJ
PEDRO LICHTINGERExecutive OfficerPARAMUS, NJ
LITSA PERPERIDISPromoterPARAMUS, NJ
ROY WALDONDirectorFORT LAUDERDALE, FL
ROMAN ROGOLDirectorNEW YORK, NY
Nintin KaushalDirectorNew York, NY

Other filings by this issuer (8)

FiledFormOfferingSold
2024-10-22D$2.1M$2.1M
2023-10-13D$971K$971K
2023-04-13D$1.4M$1.4M
2023-01-25D$1.0M$1.0M
2021-11-22D$1.1M$1.1M
2021-05-26D$78K$78K
2020-01-13D$2.0M
2018-07-02D$767K

More